title: Preliminary results of combined simultaneous transpupillary thermotherapy and ICG-based photodynamic therapy for choroidal melanoma.
abstract: OBJECTIVE
  To evaluate whether the combination of simultaneous hyperthermia by transpupillary thermotherapy and indocyanine green-based photodynamic therapy is an effective treatment for small and medium choroidal melanomas.
  
  
  METHODS
  Twenty-five patients with small and medium choroidal melanomas were treated with combined simultaneous transpupillary thermotherapy and indocyanine green-based photodynamic therapy.
  
  
  RESULTS
  The median age of the 25 patients was 64 years (range, 35 to 88 years). The pretreatment volume of the tumors ranged from 15.9 to 653.5 mm3 (mean, 118.7 +/- 146.6 mm3). After a mean of 2.4 treatments (range, 1 to 5 treatments), all of the tumors but one showed a significant volume reduction without clinical evidence of recurrences. The follow-up ranged from 6 to 59 months (mean, 12 +/- 14 months). Complications included retinal vascular occlusions, edema and superficial scarring of the macula, and rhegmatogenous retinal detachment.
  
  
  CONCLUSIONS
  The effects of combined simultaneous transpupillary thermotherapy and indocyanine green-based photodynamic therapy appears to be effective in achieving local tumor control in selected small and medium choroidal melanomas.
authors.affiliation: New England Retina Associates, Hamden, Connecticut 06518, USA.
authors.forename: Peter E
authors.initials: PE
authors.lastname: Liggett
authors.forename: Alejandro J
authors.initials: AJ
authors.lastname: Lavaque
authors.forename: Nauman A
authors.initials: NA
authors.lastname: Chaudhry
authors.forename: Eric P
authors.initials: EP
authors.lastname: Jablon
authors.forename: Hugo
authors.initials: H
authors.lastname: Quiroz-Mercado
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002830:Choroid Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D004396:Coloring Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D007208:Indocyanine Green / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010778:Photochemotherapy / Q000379:methods*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D004396:Coloring Agents; D009883:Ophthalmic Solutions; D007208:Indocyanine Green